Kimberly Orleck, PA-C, from the GHAPP Board of Trustees, shares her favorite features of the new GHAPP ACE App! Download it now for instant access to the latest GHAPP resources, all at your fingertips. ??
GHAPP
非盈利组织
Parsippany,NJ 998 位关注者
Gastroenterology & Hepatology Advanced Practice Providers Conference - September 12-14th, 2024 - Register now!
关于我们
Join over four hundred nurse practitioners and physician assistants for an in-depth review and discussion on the latest developments and important current concepts in the multidisciplinary treatment of patients with GI disorders and chronic liver disease. We are excited for the fourth annual GHAPP conference and are confident it will surpass the success we had with the 2021 conference. We had 400 live attendees and 200 virtual attendees coming from all over the country for a two-day meeting filled with scientific information and new data regarding patients with GI disorders and chronic liver disease. The conference will exclusively feature expert APP speakers and will offer an interactive learning environment to facilitate interaction between attendees and faculty on the most clinically relevant topics ranging from viral hepatitis, NASH, cirrhosis, and GI disorders: IBD, IBS, and OIC.
- 网站
-
https://www.ghapp.org
GHAPP的外部链接
- 所属行业
- 非盈利组织
- 规模
- 11-50 人
- 总部
- Parsippany,NJ
- 类型
- 非营利机构
- 创立
- 2017
- 领域
- Advanced Practice Providers、Hepatology、Gastroenterology和Medical Education
地点
-
主要
US,NJ,Parsippany
GHAPP员工
动态
-
Missed it the first time? Jonathan Yeh’s FAQ Video Module on advancements in diagnosing and staging MASH is a must-watch! View it here: https://loom.ly/4jN-lIo
Jonathan 葉景湞 Yeh, PA, MBA, discusses advancements in diagnosing and staging MASH in this new FAQ video module. Learn about non-invasive testing methods and blood tests that provide reliable staging of fibrosis in patients with MASH! Watch now at https://loom.ly/jlD3wiM .
-
Upgrade to the new GHAPP ACE 2.0, now available for download! Access FAQ video modules, medication reviews, podcasts, and GHAPP News—all at your fingertips. Stay informed and enhance your practice with this essential resource for healthcare professionals?? #healthcare #education #gastroenterology #hepatology #APPs Apple Store: https://loom.ly/rAwUn9I Google Play: https://loom.ly/cl0L43M
-
Jonathan 葉景湞 Yeh, PA, MBA, discusses advancements in diagnosing and staging MASH in this new FAQ video module. Learn about non-invasive testing methods and blood tests that provide reliable staging of fibrosis in patients with MASH! Watch now at https://loom.ly/jlD3wiM .
-
GHAPP转发了
Dr. natarajan ravendhran is leading an Innovations in the Management of MASH meeting on Tuesday, November 12th at the Red Horse Restaurant in Maryland! There is still time to register at https://loom.ly/rc3w4bM . Brian Lam Zobair Younossi
-
Missing #GHAPP2024 ? You can visit www.ghapp.org/live-events for a full list of in person events - We hope to see you soon! ??
-
Discover Resmetirom and its role in treating MASH with Robin Soto, NP! This new medication review explains the first and only FDA-approved drug for managing MASH in adults with mild to moderate fibrosis. Explore an in-depth look at how Resmetirom functions as an innovative treatment option at https://loom.ly/8tBxawA
-
The new GHAPP ACE 2.0 is now LIVE!??Keep up with all things GHAPP on the go with a new and improved version of the original GHAPP ACE app. Available for download now?? Google Play: https://loom.ly/_I_7ta0 App Store: https://loom.ly/rAwUn9I
-
The final part of the PBC Podcast Series is now available! ??? In this episode, Elizabeth Goacher, FNP, Jeremy Davis, NP and Allison Moser, MSN, RN, FNP-BC discuss key takeaways from the 2024 GHAPP National Conference on PBC, and share key updates on advancing treatment goals for better patient outcomes. You can view it here! : https://loom.ly/FOoEa98
-
Post conference highlights on MASLD/MASH from ACG is streaming live on November 7th with Nadege Gunn, MD, CPI, DABOM , Marcelo Kugelmas, MD, and Christina J. Hanson, FNP-C! Explore emerging data on MASH diagnosis and monitoring, assess current and future pharmacologic management, including GLP-1 agonists, and integrate weight loss into MASLD/MASH disease management. Register now at https://loom.ly/q-Gd518 !